Delivery Order SPE2DB22D3501-SPE2DB25FVC62
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,537.07 fixed-price contract is for the delivery of 4567580870 - Ondansetron HCL 8 mg Tablets, 30s. The contract has an ultimate completion date of March 17, 2025. This appears to be a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $9,884.96, is for the delivery of Ondansetron HCL 8 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,758.26, is for the delivery of 4,567,420,940 units of Ondansetron HCL 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,977.04, is for the delivery of 4,564,932,631 units of the pharmaceutical drug Ondansetron HCl 8 mg Tablet. The contract has a firm fixed price pricing type and an ultimate completion date of June 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,829.65, is for the delivery of 4,566,614,554 units of Ondansetron ODT 8 MG Tablets in 30-count packages. The contract has a firm fixed price and an ultimate completion date of December 5, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,152.18, is for the supply of Ondansetron ODT 8 mg tablets to support military healthcare programs. The contract type is Firm Fixed Price, and the ultimate completion date is February 7, 2025. This order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,170.40, is for the delivery of 4 mg Ondansetron HCL tablets to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,389,524 units of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $24,035.93 and a completion date of February 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,398.75, is for the delivery of Ondansetron HCL 8 mg tablets to support federal healthcare programs. It is a firm fixed price contract with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,700.37, is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...